DK641589D0 - N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer - Google Patents

N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer

Info

Publication number
DK641589D0
DK641589D0 DK641589A DK641589A DK641589D0 DK 641589 D0 DK641589 D0 DK 641589D0 DK 641589 A DK641589 A DK 641589A DK 641589 A DK641589 A DK 641589A DK 641589 D0 DK641589 D0 DK 641589D0
Authority
DK
Denmark
Prior art keywords
azetidinones
aryl
procedures
preparation
elastase inhibitors
Prior art date
Application number
DK641589A
Other languages
English (en)
Other versions
DK641589A (da
Inventor
Roger Joyeau
Randa Kobaiter
Michel Wakselman
Michele Reboud
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of DK641589D0 publication Critical patent/DK641589D0/da
Publication of DK641589A publication Critical patent/DK641589A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK641589A 1988-12-19 1989-12-18 N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer DK641589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8816732A FR2640621B1 (fr) 1988-12-19 1988-12-19 N-aryl-azetidinones, leur procede de preparation et leur utilisation comme inhibiteurs des elastases

Publications (2)

Publication Number Publication Date
DK641589D0 true DK641589D0 (da) 1989-12-18
DK641589A DK641589A (da) 1990-06-20

Family

ID=9373095

Family Applications (1)

Application Number Title Priority Date Filing Date
DK641589A DK641589A (da) 1988-12-19 1989-12-18 N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer

Country Status (11)

Country Link
US (1) US5030628A (da)
EP (1) EP0375527A1 (da)
JP (1) JPH0334966A (da)
AU (1) AU628445B2 (da)
CA (1) CA2005759A1 (da)
DK (1) DK641589A (da)
FR (1) FR2640621B1 (da)
NZ (1) NZ231817A (da)
OA (1) OA09432A (da)
PT (1) PT92612A (da)
ZA (1) ZA899725B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688785A (en) * 1991-07-23 1997-11-18 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
US5688787A (en) * 1991-07-23 1997-11-18 Schering Corporation Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof
ES2107548T3 (es) * 1991-07-23 1997-12-01 Schering Corp Compuestos de beta-lactama sustituidos utiles como agentes hipocolesterolemicos y procedimientos para su preparacion.
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
FR2755015B1 (fr) * 1996-10-25 1998-12-24 Sod Conseils Rech Applic Utilisation d'un extrait flavonoidique de ginkgo biloba substantiellement depourvu de terpenes, dans le domaine buccodentaire, et composition contenant un tel extrait
JP2001524132A (ja) * 1997-05-09 2001-11-27 スミスクライン・ビーチャム・コーポレイション ＣｏＡ−ＩＴのベータ−ラクタム阻害剤
US6274597B1 (en) * 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
WO2000063703A1 (en) 1999-04-16 2000-10-26 Schering Corporation Use of azetidinone compounds
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
WO2002058685A2 (en) * 2001-01-26 2002-08-01 Schering Corporation Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
PT1385548E (pt) * 2001-01-26 2007-08-24 Schering Corp Combinações de um inibidor ou de inibidores de absorção de esteróis com agente (s) para o tratamento de doenças vasculares
AR035533A1 (es) 2001-01-26 2004-06-02 Schering Corp Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
SK9502003A3 (en) * 2001-01-26 2003-12-02 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
WO2002058733A2 (en) * 2001-01-26 2002-08-01 Schering Corporation Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
EE05453B1 (et) 2001-03-28 2011-08-15 Schering Corporation Protsess asetidinoonvahehendite valmistamiseks
ES2275007T3 (es) * 2001-05-25 2007-06-01 Schering Corporation Uso de derivados de azetidinona sustitudos en el tratamiento de la enfermedad de alzeimer.
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
HUP0401501A3 (en) * 2001-09-21 2012-02-28 Schering Corp Treating or preventing vascular inflammation using pharmaceutical compositions containing sterol absorption inhibitor(s)
MXPA04002573A (es) 2001-09-21 2004-06-18 Schering Corp Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol.
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
JP2006519869A (ja) 2003-03-07 2006-08-31 シェーリング　コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
EP1601668B1 (en) 2003-03-07 2008-08-27 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
CA2517572C (en) 2003-03-07 2011-12-13 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP2007510659A (ja) * 2003-11-05 2007-04-26 シェーリング　コーポレイション 脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
AR047658A1 (es) 2004-02-03 2006-02-01 Cargill Inc Concentrado de proteinas y corriente acuosa con carbohidratos hidrosolubles
WO2007019178A2 (en) * 2005-08-03 2007-02-15 Cargill, Incorporated Corn protein concentrates
WO2007019227A1 (en) * 2005-08-03 2007-02-15 Cargill, Incorporated Corn protein concentrates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680391A (en) * 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US4803266A (en) * 1986-10-17 1989-02-07 Taisho Pharmaceutical Co., Ltd. 3-Oxoalkylidene-2-azetidinone derivatives

Also Published As

Publication number Publication date
ZA899725B (en) 1990-09-26
DK641589A (da) 1990-06-20
FR2640621A1 (fr) 1990-06-22
AU628445B2 (en) 1992-09-17
PT92612A (pt) 1990-06-29
CA2005759A1 (en) 1990-06-19
NZ231817A (en) 1992-03-26
EP0375527A1 (fr) 1990-06-27
US5030628A (en) 1991-07-09
AU4691789A (en) 1990-06-21
JPH0334966A (ja) 1991-02-14
OA09432A (fr) 1992-10-15
FR2640621B1 (fr) 1992-10-30

Similar Documents

Publication Publication Date Title
DK641589D0 (da) N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer
NO991815L (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
DK660788D0 (da) 2,2-difluorcyklopropylethanderivater, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel
NO905090L (no) Interleukin-1-inhibitorer og fremgangsmaate til deres fremstilling.
DK373787D0 (da) Substituerede hydrazoner, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
DK168786D0 (da) Hidtil ukendte dopaminderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
DK409886A (da) Azolyl-cyclopropyl-ethanol-derivater, fremgangsmaade til deres fremstilling og deres anvendelse
DK530689A (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
DK686888D0 (da) Aminoketaler, deres fremstilling og deres anvendelse som fungicider
NO874786D0 (no) Optisk aktive gyrasehemmere, deres fremstilling og anvendelse som antibiotika.
DK651087D0 (da) Renininhibitorer iii, deres fremstilling og anvendelse
DK360189D0 (da) S-adenosyl-methionin-decarboxylase-inhibitorer, deres fremstilling og anvendelse
DK358389D0 (da) 4-halogen-5-nitrothiazol-derivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK619989D0 (da) Dipeptidderivater, deres fremstilling og anvendelse som laegemidler
DK231089A (da) Substituerede azolthioethere, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmiddel
DK278290A (da) Substituerede 6h-pyridooe4,3-baacarbazoler og deres anvendelse som laegemidler
DK202884A (da) Azolylethyl-benzyl-ether-derivater, fremgangsmaade til deres fremstilling og deres anvendelse som fungicider
DK390186D0 (da) Thiadiazolyloxyacetamider, fremgangsmaade til deres fremstilling og deres anvendelse som herbicider
NO901758L (no) Reninhemmende dipeptider, fremgangsmaate for deres fremstilling, midler som inneholder disse og deres anvendelse.
DK355389A (da) Hydroxyalkynyl-azolylderivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK461489A (da) Dimethylmaleinimider, deres fremstilling og anvendelse som herbicider
DK184686D0 (da) (aminoalkylthio)hydroxydibenzoxepiner, en fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
DK354688A (da) Benzooe5,6aacycloheptapyridiner, kompositioner og fremgangsmaader til deres anvendelse
DK366288D0 (da) Aminoketaler, deres fremstilling og deres anvendelse som fungicider

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment